{
    "title": "BRIEF-Astrazeneca Says Ultomiris Showed Zero Relapses In Adults With Neuromyelitis Optica Spectrum Disorder",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11360147/BRIEF-Astrazeneca-Says-Ultomiris-Showed-Zero-Relapses-In-Adults-With-Neuromyelitis-Optica-Spectrum-Disorder.html",
    "date": "2022-10-27",
    "keywords": [
        "ultomiris",
        "astrazeneca",
        "nmosd",
        "trial",
        "relapse",
        "safety",
        "neuromyelitis",
        "optica",
        "spectrum",
        "disorder",
        "treatment",
        "duration",
        "proportion",
        "worsening",
        "ambulatory",
        "index",
        "subgroup",
        "body",
        "evidence",
        "inhibition",
        "championnmosd",
        "efficacy",
        "rate",
        "tolerability",
        "risk",
        "ab",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}